Synapse - October 2019

This month on Synapse

Arbitration: considerations for life science companies

In the second instalment of our Life Sciences Disputes webinar series, our experts discuss the considerations for life sciences companies in arbitrations.

Taking a new approach to European patent law

Paul England introduces A Practitioner's Guide to European Patent Law, a new book taking a different approach to substantive patent law, which was published on 17 October 2019.

New draft regulations on advertising of medical devices in Poland

Agnieszka Sztoldman discusses new draft regulations on medical devices currently being drawn up by the Polish Ministry of Health.

Patenting of gene and protein sequences: an EU and US perspective

Josie Miller provides an overview of the law and guidance surrounding the patentability of gene and protein sequences, focusing on the differences between the EU and US regimes.

Patents diary: October 2019

Judith Krens and Emma Jansen explore the Biogen and Celltrion case, in which the suspension of proceedings pending a decision by the European Patent Office and the assignment of a priority right are discussed, and Paul England looks at invalidity by "uncertainty".